Analysis
new
Racine
Analysis
new
Exploration
Accueil
Racine
Racine

Serveur d'exploration Covid (26 mars)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Le cluster against - fight

Terms

22against
5fight
6chloroquine
3battle

Associations

Freq.WeightAssociation
33against - fight
33against - chloroquine
33against - battle
Documents par ordre de pertinence
000132 (2020) Jin Hong Yoo [Corée du Sud]The Fight against the 2019-nCoV Outbreak: an Arduous March Has Just Begun.
000134 (2020) Zixing Huang [République populaire de Chine] ; Shuang Zhao [République populaire de Chine] ; Zhenlin Li [République populaire de Chine] ; Weixia Chen [République populaire de Chine] ; Lihong Zhao [République populaire de Chine] ; Lipeng Deng [République populaire de Chine] ; Bin Song [République populaire de Chine]The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management and Infection Control in a Radiology Department.
000135 (2020) Manica Negahdaripour [Iran]The Battle Against COVID-19: Where Do We Stand Now?
000276 (2020) Christian A. Devaux [France] ; Jean-Marc Rolain [France] ; Philippe Colson [France] ; Didier Raoult [France]New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
000334 (2020) Tony Y. Hu [États-Unis] ; Matthew Frieman [États-Unis] ; Joy Wolfram [États-Unis]Insights from nanomedicine into chloroquine efficacy against COVID-19.
000341 (2020) Joana Gonçalves-SáIn the fight against the new coronavirus outbreak, we must also struggle with human bias
000439 (2020) Yue Zheng ; Wei LaiDermatology staff participate in fight against Covid-19 in China.
000607 (2020) Amirhossein Takian [Iran] ; Azam Raoofi [Iran] ; Sara Kazempour-Ardebili [Iran]COVID-19 battle during the toughest sanctions against Iran.
000650 (2020) Zahra Sahraei [Iran] ; Minoosh Shabani [Iran] ; Shervin Shokouhi [Iran] ; Ali Saffaei [Iran]Aminoquinolines Against Coronavirus Disease 2019 (COVID-19): Chloroquine or Hydroxychloroquine.
000067 (2020) Haiou Li [République populaire de Chine] ; Yunjiao Zhou [République populaire de Chine] ; Meng Zhang [République populaire de Chine] ; Haizhou Wang [République populaire de Chine] ; Qiu Zhao [République populaire de Chine] ; Jing Liu [République populaire de Chine]Updated approaches against SARS-CoV-2.
000084 (2020) Shan Lu [États-Unis]Timely development of vaccines against SARS-CoV-2.
000097 (2020) Helena Legido-Quigley [Singapour] ; José Tomás Mateos-García [Espagne] ; Vanesa Regulez Campos [Espagne] ; Montserrat Gea-Sánchez [Espagne] ; Carles Muntaner [Canada] ; Martin Mckee [Royaume-Uni]The resilience of the Spanish health system against the COVID-19 pandemic.
000194 (2020) Manli Wang [République populaire de Chine] ; Ruiyuan Cao [République populaire de Chine] ; Leike Zhang [République populaire de Chine] ; Xinglou Yang [République populaire de Chine] ; Jia Liu [République populaire de Chine] ; Mingyue Xu [République populaire de Chine] ; Zhengli Shi [République populaire de Chine] ; Zhihong Hu [République populaire de Chine] ; Wu Zhong [République populaire de Chine] ; Gengfu Xiao [République populaire de Chine]Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
000306 (2020) Li Runfeng [République populaire de Chine] ; Hou Yunlong [République populaire de Chine] ; Huang Jicheng [République populaire de Chine] ; Pan Weiqi [République populaire de Chine] ; Ma Qinhai [République populaire de Chine] ; Shi Yongxia [République populaire de Chine] ; Li Chufang [République populaire de Chine] ; Zhao Jin [République populaire de Chine] ; Jia Zhenhua [République populaire de Chine] ; Jiang Haiming [République populaire de Chine] ; Zheng Kui [République populaire de Chine] ; Huang Shuxiang [République populaire de Chine] ; Dai Jun [République populaire de Chine] ; Li Xiaobo [République populaire de Chine] ; Hou Xiaotao [République populaire de Chine] ; Wang Lin [République populaire de Chine] ; Zhong Nanshan [République populaire de Chine] ; Yang Zifeng [République populaire de Chine]Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2).
000308 (2020) Qiang Wang [République populaire de Chine] ; Chaoran Yu [République populaire de Chine]Letter to editor: Role of masks/respirator protection against 2019-novel coronavirus (COVID-19).
000354 (2020) Jia Liu [République populaire de Chine] ; Ruiyuan Cao [République populaire de Chine] ; Mingyue Xu [République populaire de Chine] ; Xi Wang [République populaire de Chine] ; Huanyu Zhang [République populaire de Chine] ; Hengrui Hu [République populaire de Chine] ; Yufeng Li [République populaire de Chine] ; Zhihong Hu [République populaire de Chine] ; Wu Zhong [République populaire de Chine] ; Manli Wang [République populaire de Chine]Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
000357 (2020) John ZarocostasHow to fight an infodemic.
000429 (2020) Ki Tae Kwon [Corée du Sud] ; Jae Hoon Ko [Corée du Sud] ; Heejun Shin [Corée du Sud] ; Minki Sung [Corée du Sud] ; Jin Yong Kim [Corée du Sud]Drive-Through Screening Center for COVID-19: a Safe and Efficient Screening System against Massive Community Outbreak.
000485 (2020) Jon Cohen ; Kai KupferschmidtCountries test tactics in 'war' against COVID-19.
000506 (2020) B. Robson [États-Unis, Royaume-Uni]Computers and viral diseases. Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus
000511 (2020) Carolina Oi Lam UngCommunity pharmacist in public health emergencies: Quick to action against the coronavirus 2019-nCoV outbreak.
000639 (2020) Lisi Deng [République populaire de Chine] ; Chunna Li [République populaire de Chine] ; Qi Zeng [République populaire de Chine] ; Xi Liu [République populaire de Chine] ; Xinghua Li [République populaire de Chine] ; Haitang Zhang [République populaire de Chine] ; Zhongsi Hong [République populaire de Chine] ; Jinyu Xia [République populaire de Chine]Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study.
000654 (2020) Caroline O. Buckee [États-Unis] ; Satchit Balsari [États-Unis] ; Jennifer Chan [États-Unis] ; Mercè Crosas [États-Unis] ; Francesca Dominici [États-Unis] ; Urs Gasser [États-Unis] ; Yonatan H. Grad [États-Unis] ; Bryan Grenfell [États-Unis] ; M Elizabeth Halloran [États-Unis] ; Moritz U G. Kraemer [Royaume-Uni] ; Marc Lipsitch [États-Unis] ; C Jessica E. Metcalf [États-Unis] ; Lauren Ancel Meyers [États-Unis] ; T Alex Perkins [États-Unis] ; Mauricio Santillana [États-Unis] ; Samuel V. Scarpino [États-Unis] ; Cecile Viboud [États-Unis] ; Amy Wesolowski [États-Unis] ; Andrew Schroeder [États-Unis]Aggregated mobility data could help fight COVID-19.
000660 (2020) Andrea Cortegiani [Italie] ; Giulia Ingoglia [Italie] ; Mariachiara Ippolito [Italie] ; Antonino Giarratano [Italie] ; Sharon Einav [Israël]A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19.
000690 (2019) Lan Li ; Xiaoming Yu ; Haoming Zhang ; Haiwei Cheng ; Liting Hou ; Qisheng Zheng ; Jibo HouIn vitro antiviral activity of Griffithsin against porcine epidemic diarrhea virus
000715 (2017) Min Zhao [République populaire de Chine] ; Hangjie Zhang [République populaire de Chine] ; Kefang Liu [République populaire de Chine] ; George F. Gao [République populaire de Chine] ; William J. Liu [République populaire de Chine]Human T-cell immunity against the emerging and re-emerging viruses
000802 (2005) Man Cheng [République populaire de Chine] ; Ceci W. L. Chan [République populaire de Chine] ; Randy C. F. Cheung [République populaire de Chine] ; Rama Kamesh Bikkavilli [République populaire de Chine] ; Qi Zhao [République populaire de Chine] ; Shannon W. N. Au [République populaire de Chine] ; Paul K. S. Chan [République populaire de Chine] ; Susanna S. T. Lee [République populaire de Chine] ; Gregory Cheng [République populaire de Chine] ; Walter K. K. Ho [République populaire de Chine] ; Wing-Tai Cheung [République populaire de Chine]Cross-reactivity of antibody against SARS-coronavirus nucleocapsid protein with IL-11
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021